Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative duloxetine for postoperative pain after total hip or knee arthroplasty
2013-004313-41Phase 3Active
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of duloxetine in hip osteoarthritis and knee osteoarthritis (OA) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Postoperative pain at 6 months. Started Feb 2014; status: active.
02
Drugs
duloxetine
03
Conditions
hip osteoarthritisknee osteoarthritis (OA)
Beyond the preview
Go deeper on 2013-004313-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004313-41.